Mind Medicine, Inc – trial to test LSD microdosing as an ADHD treatment
Cannabis Law Report
FEBRUARY 14, 2020
Mind Medicine, Inc. , a Canadian biotech firm, is entering Phase II clinical trials for two experimental treatments. The other trial will test LSD microdosing as an ADHD treatment. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction.
Let's personalize your content